Evaluation of the Clinical Benefit of the Aktiia Blood Pressure Monitoring for Early Awareness of Hypertension and Prediction of Cardiovascular Risk

Because Aktiia S.A. has been the first-ever company to put in the market an Optical Blood Pressure Monitoring device, there is a need for Aktiia S.A. to correlate for the first time continual Blood Pressure monitoring and the evolution of environmental and health factors to improve hypertension management.

NCT Number	NCT06670677
Lead Sponsor	Aktiia SA
Conditions	Hypertension, Cardiovascular Risk, Blood Pressure Check (Hypertension Screening)
Enrollment	15,000 participants
Start Date	2025-05-12
Primary Completion	2035-05-31 (estimated)
Study Completion	2035-05-31 (estimated)
Updated on ClinicalTrials.gov	2025-05-14